N-Boc-L-trans-4,5-Methanoproline
N-Boc-L-trans-4,5-Methanoproline Basic information
- Product Name:
- N-Boc-L-trans-4,5-Methanoproline
- Synonyms:
-
- N-Boc-L-trans-4,5-Methanoproline
- (1R,3S,5R)-2-[(tert-Butoxy)carbonyl]-2-azabicyclo[3.1.0]hexane-3-carboxyl+
- N-Boc-L-trans-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
- 2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) ester, (1R,3S,5R)-
- EOS-61213
- (1R,3S,5R)-2-(tert-butoxyCARBONYL)-2-AZABICLO[3.1.0]hexane-3-carboxylic acid
- (1R,3S,5R)-2-Boc-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid
- N-tert-butoxycarbonyl-l-trans-2-azabicyclo 3.1.0 hexane-3-carboxylic acid
- CAS:
- 197142-34-0
- MF:
- C11H17NO4
- MW:
- 227.26
- EINECS:
- 815-186-6
- Mol File:
- 197142-34-0.mol
N-Boc-L-trans-4,5-Methanoproline Chemical Properties
- Boiling point:
- 355.9±25.0 °C(Predicted)
- Density
- 1.276±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- Acetone (Slightly, Sonicated), DMSO (Slightly, Sonicated), Methanol (Slightly, Heated)
- pka
- 4.03±0.20(Predicted)
- form
- Solid
- color
- White to Pale Yellow
- Stability:
- Hygroscopic
- InChI
- InChI=1S/C11H17NO4/c1-11(2,3)16-10(15)12-7-4-6(7)5-8(12)9(13)14/h6-8H,4-5H2,1-3H3,(H,13,14)/t6-,7-,8+/m1/s1
- InChIKey
- VXIIZQXOIDYWBS-PRJMDXOYSA-N
- SMILES
- [C@]12([H])[C@]([H])(C1)C[C@@H](C(O)=O)N2C(OC(C)(C)C)=O
N-Boc-L-trans-4,5-Methanoproline Usage And Synthesis
Uses
N-Boc-L-trans-4,5-Methanoproline belongs to carboxylic acid derivatives and can be used as pharmaceutical intermediates.
Uses
1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid acts as a reagent in the preparation of fused bicycles end-capped with peptide derivatives as HCV inhibitors. Synthesis of (tert-butoxycarbonyl)azabicyclohexanecarboxylic acid via stereoselective cyclopropanation of pyrroline
Synthesis
197142-33-9
197142-34-0
Tert-butyl (1R,3S,5R)-3-(hydroxymethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate (900 mg, 4.22 mmol, 1.00 eq.) was used as a feedstock and dissolved in a mixed solvent of acetonitrile (10 mL) and carbon tetrachloride (10 mL). To this solution was added an aqueous (10 mL) solution of sodium periodate (2.72 g, 12.72 mmol, 3.00 equiv) and ruthenium trichloride hydrate (44 mg, 0.20 mmol). The reaction mixture was stirred overnight at room temperature. After completion of the reaction, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic phase was washed with brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The target product (1R,3S,5R)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid (620 mg, 65% yield) was obtained as a brown solid.
References
[1] Angewandte Chemie (International Edition in English), 1997, vol. 36, # 17, p. 1881 - 1884
[2] Patent: WO2015/52264, 2015, A1. Location in patent: Paragraph 01524; 01525
[3] Patent: WO2012/18325, 2012, A1. Location in patent: Page/Page column 145
[4] Patent: WO2012/48421, 2012, A1. Location in patent: Page/Page column 26; 29
[5] Angewandte Chemie - International Edition, 2015, vol. 54, # 45, p. 13268 - 13272
N-Boc-L-trans-4,5-MethanoprolineSupplier
- Tel
- 021-20432219 13918097649
- li_jinfei@acblock-lab.com
- Tel
- 512-68242903 13916956214
- sales@victory-pharm.com
- Tel
- +86-188369842 +86-15618151133
- 188369842@qq.com
- Tel
- 0510-86838766 13636419861
- 2258830676@qq.com
- Tel
- 400-6009262 16621234537
- chenyj@titansci.com
N-Boc-L-trans-4,5-Methanoproline(197142-34-0)Related Product Information
- BOC-DL-PROLINE ETHYL ESTER
- (1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE 2,2,2-TRIFLUOROACETIC ACID
- (1S,3R,5S)-2-tert-Butyl 3-ethyl 2-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-
- Saxagliptin hydrochloride
- 1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-
- (S) - N- Boc- adamantylglycine
- (S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester
- 2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) 3-ethyl ester, (1S,3S,5S)-
- (2R)-1,2-Pyrrolidinedicarboxylic acid 1-tert-butyl 2-ethyl ester
- (1S,3S,5S)-2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID
- DSLXQSYLYSTVKT-ONZQNKQFSA-N
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
- AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-
- N-Boc-L-trans-4,5-methanoproline ethyl ester
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
- Saxagliptin O-β-D-glucuronide